Well it would be great but surely way over optimistic. There's three phases of the human trials to go through and then the licensing process. Five to seven years seems more likely. However at least we are seeing Cynata exposure in the media which is in itself a new dawn...
- Forums
- ASX - By Stock
- Ann: Final Preclinical Asthma Study Confirms Efficacy
Well it would be great but surely way over optimistic. There's...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
|
|||||
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $37.91M |
Open | High | Low | Value | Volume |
21.0¢ | 21.0¢ | 20.5¢ | $11.26K | 53.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7339 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 32225 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7339 | 0.205 |
3 | 131303 | 0.200 |
2 | 68825 | 0.195 |
3 | 122713 | 0.190 |
3 | 15055 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 32225 | 2 |
0.230 | 161397 | 3 |
0.240 | 10000 | 1 |
0.255 | 187726 | 1 |
0.270 | 30000 | 1 |
Last trade - 15.39pm 23/08/2024 (20 minute delay) ? |
CYP (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online